Is Merck & Co., Inc. overvalued?

Merck & Co., Inc. (MRK) looks fairly valued — trading about 6% below its fair value.

Fairly valued

Price

$132.93

Fair value

$141.50

Current P/E

18.3

Normal P/E

19.4

Market cap

$328.31B

Dividend yield

2.6%

Return on equity

6.6%

Sector

Healthcare

Fair value compares MRK's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks